Dr Lydia Makaroff elected as President of the World Bladder Cancer Patient Coalition

Lydia Makaroff - President World Bladder Cancer Patient Coalition

The World Bladder Cancer Patient Coalition Board of Director selects Dr Lydia Makaroff as the President of the organisation, succeeding Ken Bagshaw, who remains on the Board.

Today, the World Bladder Cancer Patient Coalition is delighted to announce the election of Dr Lydia Makaroff as the new President of the organisation. Lydia succeeds founding President Ken Bagshaw, who has been elected President in June 2019 and was instrumental in the establishment and success of the coalition thus far.

‘Bladder Cancer Digital World Tour’ concludes the Bladder Cancer Awareness Month shining a light on bladder cancer impact worldwide

Thank you - WBCPC Members - Bladder Cancer Awareness Month

To boost global awareness of bladder cancer, a coalition of dedicated bladder cancer patient groups and advocates has delivered the Bladder Cancer Awareness Digital World Tour which wrapped up yesterday. This is a unique knowledge-sharing initiative that gives insight into bladder cancer impact in 31 countries across the world. The Tour ran throughout Bladder Cancer Awareness Month, and is organised by the World Bladder Cancer Patient Coalition (WBCPC) and its member organisations.

The SIU and WBCPC enter formal agreement to advance bladder cancer patient care

Bladder cancer is the 10th most common cancer globally with 60% of cases and 50% of deaths occurring in resource-constrained countries. In an effort to address unmet needs in bladder cancer, the Société Internationale d’Urologie (SIU) and the World Bladder Cancer Patient Coalition (WBCPC) are pleased to announce that they have entered into a formal two-year partnership with the aim to improve the quality of bladder cancer best practices and standards of care worldwide.

Now available in French: Start-up guide for bladder cancer groups

Bladder-Cancer-Patient-Support-Group

English

Today, we are thrilled to launch our French version of the Start-up guide for bladder cancer patient groups , which is an important step in our outreach and community plans.

Bladder cancer patient groups across the globe, small and large, have an important role to play in improve the situation for patients and their families. It is our vision to see a bladder cancer patient group in every country, and today we are proud to launch our Know the basis: A start-up guide for bladder cancer patient groups in French.

Joint letter on COVID-19 and cancer

Joint letter on covid-19 and cancer WBCPC

The World Bladder Cancer Patient Coalition is pleased to join a global campaign together with almost 300 organisations to endorse the Joint letter on Covid-19 and cancer as a call to action. The co-signing organisations express commitment and readiness to support governments in addressing the challenges in an effort to help people affected by cancer, including bladder cancer, around the world.

We recognise that healthcare systems are under unprecedented pressure due to the COVID-19 pandemic and that the global crisis has not ended yet,

Recognising the incredible women in the bladder cancer community

Women-bladder-cancer-family

On the occasion of International Women’s Day, the World Bladder Cancer Patient Coalition highlights the impact of bladder cancer on women and celebrates women patient advocates around the world.

Bladder cancer and women

Although bladder cancer is often considered a disease of older men, bladder cancer also affects women. Around 1 in 4 cases of bladder cancer will be diagnosed in women. Whilst it is more prevalent in men, studies show that women are more likely to be diagnosed with more advanced tumours.

COVID-19: Impact on cancer patient organisations – Report

COVID-19 impact on cancer patient organisations

On the occasion of the World Cancer Day, the Global Cancer Coalitions Network (GCCN), of which WBCPC is a member, has launched a report COVID-19: Impact on Cancer Patient Organisations Worldwide in 2020.

Launched at the GCCN virtual event Coalition Connection on February 4, the survey results highlight the impact of the COVID-19 pandemic on cancer patient groups and show that patient advocacy organisations face a clear and present danger with few signs of reprieve as the pandemic continues.

Together, for bladder cancer patients on World Cancer Day

I am a global voice and I will raise awareness - World Cancer Day

On the occasion of the World Cancer Day on 4 February, the World Bladder Cancer Patient Coalition is proud to join the international cancer community in shining light on cancer challenges and our collective efforts to overcome them.

Together, all our actions matter. Throughout 2020 we saw how much we could achieve when working towards a common goal, even during the most challenging year in recent history. We celebrate World Cancer Day, highlighting the strength of even the smallest individual actions and the urgent need for collaboration.

Bladder cancer patient studies wanted for major urology congress

EAU21 Patient poster track banner

EAU21, Europe’s largest Annual Urology Congress, will take place in Milan from 9 through 12 July 2021. The European Association of Urology (EAU) provides patient organisations and patient advocates with a stage to voice their goals and objectives at this congress.

The patient-physician disconnect will be one of the themes at the annual EAU Congress in Milan 2021. The EAU offers patient advocates the opportunity to present their research into diagnostics,

COVID-19 Vaccinations and patients with cancer – An ESMO Call to action

A male patient receiving a vaccine

Today, the European Society for Medical Oncology (ESMO) has launched a Call to Action COVID-19 Vaccinations and patients with cancer: Vaccinate. Monitor. Educate. 

The document calls for the European Union (EU) Member States’ COVID-19 vaccination strategies to consider prioritising cancer patients in line with the WHO principles aiming to reduce deaths and disease burden. ESMO encourages the countries to collect data in order to monitor the effects of the vaccines in the vulnerable population and take the lead in education and instilling confidence amongst public and patients with cancer.